Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ranolazine Extended Release 1000mg Tablets
Therapeutic Category
Hypertension/ Blood Pressure, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹145/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ranfoli SR 1000 Tablet contains Ranolazine 1000mg in an extended-release formulation, designed to provide sustained control of chronic angina symptoms. Ranolazine works by improving the efficiency of oxygen use in heart muscles without significantly affecting heart rate or blood pressure. It acts by inhibiting the late sodium current in cardiac cells, thereby reducing intracellular calcium overload and improving myocardial relaxation and perfusion. This makes it an effective option for patients who require long-term angina management or who are not responding adequately to conventional therapies.
Most patients tolerate Ranolazine well. However, some may experience dizziness, constipation, nausea, or headache. Rare but serious side effects can include QT interval prolongation or renal function changes, particularly in patients with pre-existing cardiac or renal conditions.
Ranfoli SR 1000 is indicated for the treatment of chronic stable angina in adults. It helps reduce the frequency of angina attacks, improve exercise tolerance, and decrease the need for nitrate medications. It is often used as an adjunct to other anti-anginal drugs like beta-blockers or calcium channel blockers.
Ranolazine should be used strictly under medical supervision. It is not suitable for use during acute angina attacks. Caution is advised in patients with hepatic impairment, renal dysfunction, or those taking QT-prolonging drugs. Avoid grapefruit juice while on this medication.
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.
Composition : Labetalol (5mg/1ml)
Composition : Torsemide (10mg/ml) Injection
Composition : Amlodipine 10 mg Tablet
Composition : Amlodipine 2.5 mg Tablet
Composition : Amlodipine 5 mg Tablet
Composition : Amlodipine 5mg + Atenolol 50mg Tablet
Composition : Azelnidipine 16 Tablet
Composition : Azelnidipine 8mg Tablet
Composition : Benidipine 4mg + Telmisartan 40mg Tablet
Composition : Bisoprolol 1.25 MG Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ranfoli SR 1000 Tablet has strong demand in the cardiac and cardiovascular care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on heart-care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of chronic angina (chest pain), ischemic heart conditions, and cardiovascular disorders. Ranolazine Extended Release 1000mg helps improve blood flow efficiency in the heart and reduces angina symptoms without significantly affecting heart rate or blood pressure The extended-release formulation provides prolonged therapeutic action and improved patient compliance.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ranfoli SR 1000 Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong cardiologist and physician prescriptions, chronic long-term therapy demand, growing cardiac-care market, reliable supply chain support, and good margins in cardiovascular medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.